NCT01899768 - GSK2339345 Hypertussive Challenge Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Cough

Interventions

DRUG

GSK2339345

Clear colorless solution in clear glass vial for oral inhalation via aqueous droplet inhaler with unit dose strength of 1000 microgram (mcg) inhaled in two actuations.

DRUG

Placebo

Clear colorless solution of 0.9% sodium chloride for oral inhalation via aqueous droplet inhaler inhaled in two actuations.

Trial Locations (2)

M23 9LT

GSK Investigational Site, Manchester

BT9 7AB

GSK Investigational Site, Belfast